VENKYS (INDIA)
Back to Balance Sheet
|
VENKYS (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹666 Cr | ₹665 Cr | ₹641 Cr | ₹626 Cr | ₹705 Cr |
What is the latest Total Current Liabilities ratio of VENKYS (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹666 Cr |
Mar2023 | ₹665 Cr |
Mar2022 | ₹641 Cr |
Mar2021 | ₹626 Cr |
Mar2020 | ₹705 Cr |
How is Total Current Liabilities of VENKYS (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹666 Cr | 0.20 | |
Mar2023 | ₹665 Cr | 3.62 | |
Mar2022 | ₹641 Cr | 2.47 | |
Mar2021 | ₹626 Cr | -11.28 | |
Mar2020 | ₹705 Cr | - |
Compare Total Current Liabilities of peers of VENKYS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENKYS (INDIA) | ₹2,350.1 Cr | 5.5% | 4.4% | 3.5% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,078.0 Cr | 5.8% | 9.3% | 17.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,823.4 Cr | 7.9% | 33% | 99.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,304.3 Cr | 0.6% | -4.3% | -47.8% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹489.4 Cr | 7.6% | 4.5% | NA | Stock Analytics | |
INDO US BIOTECH | ₹307.6 Cr | -10.4% | -24.8% | -40.9% | Stock Analytics |
VENKYS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENKYS (INDIA) | 5.5% |
4.4% |
3.5% |
SENSEX | -1.3% |
4.2% |
3.6% |
You may also like the below Video Courses